Abstract
Topoisomerases relax the DNA superhelical tension that arises in cells as a result of several nuclear processes, including transcription, replication and recombination. Recently determined crystal structures of human topoisomerase I in complex with DNA and of the 27 kDa catalytic domain of the vaccinia virus topoisomerase have advanced our understanding of the eukaryotic type IB topoisomerases. These recent structural results provide insights into functional aspects of these topoisomerases, including their DNA binding, strand cleavage and religation activities, as well as the mechanism that these enzymes use to relax DNA superhelical tension. In addition, two proposed models of the anticancer drug camptothecin bound to a covalent complex of human topoisomerase I and DNA suggest a structural basis for the mode of action of the drug.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Antineoplastic Agents, Phytogenic / chemistry
-
Antineoplastic Agents, Phytogenic / metabolism
-
Antineoplastic Agents, Phytogenic / pharmacology
-
Camptothecin / chemistry
-
Camptothecin / metabolism
-
Camptothecin / pharmacology
-
DNA Topoisomerases, Type I / chemistry*
-
DNA Topoisomerases, Type I / classification
-
DNA Topoisomerases, Type I / metabolism*
-
DNA, Superhelical / chemistry
-
DNA, Superhelical / metabolism
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / metabolism
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Models, Molecular
-
Nucleic Acid Conformation
-
Protein Conformation
-
Substrate Specificity
-
Vaccinia virus / enzymology
Substances
-
Antineoplastic Agents, Phytogenic
-
DNA, Superhelical
-
Enzyme Inhibitors
-
DNA Topoisomerases, Type I
-
Camptothecin